B. Cepacia Hits ICUs Again, Raises Manufacturing Controls Questions
Executive Summary
Another outbreak of B. cepacia at hospital intensive care units in multiple states implicates manufacturing and supply chain controls on aqueous non-sterile drug products, particularly for those marketed over the counter under OTC monographs.